119 related articles for article (PubMed ID: 16246418)
1. Granulocytic maturation in cultures of acute myeloid leukemia is not always accompanied by increased apoptosis.
Garattini E; Terao M
Leuk Res; 2006 May; 30(5):519-20. PubMed ID: 16246418
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta1 inhibits all-trans retinoic acid-induced apoptosis.
Soucek K; Pacherník J; Kubala L; Vondrácek J; Hofmanová J; Kozubík A
Leuk Res; 2006 May; 30(5):607-23. PubMed ID: 16242776
[TBL] [Abstract][Full Text] [Related]
3. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells.
Sylvester PW; Shah S
Asia Pac J Clin Nutr; 2005; 14(4):366-73. PubMed ID: 16326643
[TBL] [Abstract][Full Text] [Related]
4. Dimethyl sulfoxide potentiates death receptor-mediated apoptosis in the human myeloid leukemia U937 cell line through enhancement of mitochondrial membrane depolarization.
Vondrácek J; Soucek K; Sheard MA; Chramostová K; Andrysík Z; Hofmanová J; Kozubík A
Leuk Res; 2006 Jan; 30(1):81-9. PubMed ID: 15998540
[TBL] [Abstract][Full Text] [Related]
5. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
Hamaï A; Richon C; Meslin F; Faure F; Kauffmann A; Lecluse Y; Jalil A; Larue L; Avril MF; Chouaib S; Mehrpour M
Oncogene; 2006 Dec; 25(58):7618-34. PubMed ID: 16983347
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor-related apoptosis-inducing ligand-mediated proliferation of tumor cells with receptor-proximal apoptosis defects.
Baader E; Toloczko A; Fuchs U; Schmid I; Beltinger C; Ehrhardt H; Debatin KM; Jeremias I
Cancer Res; 2005 Sep; 65(17):7888-95. PubMed ID: 16140959
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression: DR5 and caspase 8 are key players.
Hesry V; Piquet-Pellorce C; Travert M; Donaghy L; Jégou B; Patard JJ; Guillaudeux T
Prostate; 2006 Jun; 66(9):987-95. PubMed ID: 16541419
[TBL] [Abstract][Full Text] [Related]
8. Application of flow cytometry to molecular medicine: detection of tumor necrosis factor-related apoptosis-inducing ligand receptors in acute myeloid leukaemia blasts.
Cappellini A; Mantovani I; Tazzari PL; Grafone T; Martinelli G; Cocco L; Martelli AM
Int J Mol Med; 2005 Dec; 16(6):1041-8. PubMed ID: 16273284
[TBL] [Abstract][Full Text] [Related]
9. FLICE-like inhibitory protein blocks transforming growth factor beta 1-induced caspase activation and apoptosis in prostate epithelial cells.
Nastiuk KL; Yoo K; Lo K; Su K; Yeung P; Kutaka J; Danielpour D; Krolewski JJ
Mol Cancer Res; 2008 Feb; 6(2):231-42. PubMed ID: 18314484
[TBL] [Abstract][Full Text] [Related]
10. Interactive effects of histone deacetylase inhibitors and TRAIL on apoptosis in human leukemia cells: involvement of both death receptor and mitochondrial pathways.
Shankar S; Singh TR; Fandy TE; Luetrakul T; Ross DD; Srivastava RK
Int J Mol Med; 2005 Dec; 16(6):1125-38. PubMed ID: 16273296
[TBL] [Abstract][Full Text] [Related]
11. Triptolide sensitizes resistant cholangiocarcinoma cells to TRAIL-induced apoptosis.
Panichakul T; Intachote P; Wongkajorsilp A; Sripa B; Sirisinha S
Anticancer Res; 2006; 26(1A):259-65. PubMed ID: 16475706
[TBL] [Abstract][Full Text] [Related]
12. COX-2 inhibitors sensitize human hepatocellular carcinoma cells to TRAIL-induced apoptosis.
Yamanaka Y; Shiraki K; Inoue T; Miyashita K; Fuke H; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T
Int J Mol Med; 2006 Jul; 18(1):41-7. PubMed ID: 16786154
[TBL] [Abstract][Full Text] [Related]
13. Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL.
Altucci L; Rossin A; Raffelsberger W; Reitmair A; Chomienne C; Gronemeyer H
Nat Med; 2001 Jun; 7(6):680-6. PubMed ID: 11385504
[TBL] [Abstract][Full Text] [Related]
14. Crosstalk between extrinsic and intrinsic cell death pathways in pancreatic cancer: synergistic action of estrogen metabolite and ligands of death receptor family.
Basu A; Castle VP; Bouziane M; Bhalla K; Haldar S
Cancer Res; 2006 Apr; 66(8):4309-18. PubMed ID: 16618756
[TBL] [Abstract][Full Text] [Related]
15. Time sequence of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and cisplatin treatment is responsible for a complex pattern of synergistic cytotoxicity.
Kim YH; Lee YJ
J Cell Biochem; 2006 Aug; 98(5):1284-95. PubMed ID: 16514644
[TBL] [Abstract][Full Text] [Related]
16. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL
Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349
[TBL] [Abstract][Full Text] [Related]
17. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
[TBL] [Abstract][Full Text] [Related]
18. Trichostatin A sensitizes TRAIL-resistant myeloma cells by downregulation of the antiapoptotic Bcl-2 proteins.
Fandy TE; Srivastava RK
Cancer Chemother Pharmacol; 2006 Oct; 58(4):471-7. PubMed ID: 16435155
[TBL] [Abstract][Full Text] [Related]
19. FADD deficiency sensitises Jurkat T cells to TNF-alpha-dependent necrosis during activation-induced cell death.
Lawrence CP; Chow SC
FEBS Lett; 2005 Nov; 579(28):6465-72. PubMed ID: 16289096
[TBL] [Abstract][Full Text] [Related]
20. [Synergistic induction of apoptosis by the combination of TRAIL and low dose adriamycin in human osteosarcoma cell line U2OS].
Yang DS; Miao XD; Ye ZM; Xu YS
Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):595-7. PubMed ID: 16438867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]